Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the US
PaperCitations, authors & open-access status
Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the US is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 42 citations, 2014 year and bronze oa status.
42
Citations
2014
Year
bronze
OA Status